Patents by Inventor Amanpreet Kaur

Amanpreet Kaur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10166241
    Abstract: The invention is based on a finding that silencing HDAC4gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: January 1, 2019
    Assignee: Turun yliopisto
    Inventors: Jukka Westermarck, Amanpreet Kaur
  • Patent number: 10094834
    Abstract: The present invention relates to a method of selecting individualized brain cancer therapy on the basis of the patient's PME-1 expression level in the diseased tissue.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: October 9, 2018
    Assignee: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, Amanpreet Kaur
  • Publication number: 20180226247
    Abstract: A heterojunction device is provided. The heterojunction device includes a silicon (Si) substrate; and a film of silicon carbide (SiC) deposited on a surface of the Si substrate. The SiC has a Si:C ratio that increases or decreases from a SiC surface in contact with the Si substrate to an opposing SiC surface that is not in contact with the Si substrate.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 9, 2018
    Applicant: Board of Trustees of Michigan State University
    Inventors: Premjeet CHAHAL, Tim HOGAN, Amanpreet KAUR
  • Patent number: 9960037
    Abstract: A method for forming a compound on a substrate is provided. The method includes depositing a composition onto a surface of a substrate; illuminating the composition and the substrate with pulsed energy; melting the substrate and decomposing the composition simultaneously; and forming a compound on the substrate. A first component of the compound is derived from the substrate and a second component of the compound is derived from the composition.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: May 1, 2018
    Assignee: Board Of Trustees Of Michigan State University
    Inventors: Premjeet Chahal, Tim Hogan, Amanpreet Kaur
  • Publication number: 20170040167
    Abstract: A method for forming a compound on a substrate is provided. The method includes depositing a composition onto a surface of a substrate; illuminating the composition and the substrate with pulsed energy; melting the substrate and decomposing the composition simultaneously; and forming a compound on the substrate. A first component of the compound is derived from the substrate and a second component of the compound is derived from the composition.
    Type: Application
    Filed: August 3, 2016
    Publication date: February 9, 2017
    Applicant: Board of Trustees of Michigan State University
    Inventors: Premjeet CHAHAL, Tim HOGAN, Amanpreet KAUR
  • Patent number: 9476050
    Abstract: The invention is based on a finding that silencing PME-1 gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: October 25, 2016
    Assignee: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, John Eriksson, Amanpreet Kaur, Emilia Peuhu
  • Publication number: 20150209369
    Abstract: The invention is based on a finding that silencing HDAC4gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions.
    Type: Application
    Filed: July 11, 2013
    Publication date: July 30, 2015
    Applicant: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, Amanpreet Kaur
  • Publication number: 20150204877
    Abstract: The present invention relates to a method of selecting individualized brain cancer therapy on the basis of the patient's PME-1 expression level in the diseased tissue.
    Type: Application
    Filed: August 29, 2013
    Publication date: July 23, 2015
    Applicant: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, Amanpreet Kaur
  • Publication number: 20140135377
    Abstract: The invention is based on a finding that silencing PME-1 gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions.
    Type: Application
    Filed: June 15, 2012
    Publication date: May 15, 2014
    Applicant: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, John Eriksson, Amanpreet Kaur, Emilia Peuhu